Demant A/S (DEMANT.CO) stock: key figures, P/E, revenue and dividend
Health Care · Denmark · ISIN DK0060738599
Demant A/S financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 22.42 bn DKK | 23.08 bn DKK |
| Gross profit | 17.09 bn DKK | 16.11 bn DKK |
| Operating income | 4.71 bn DKK | 4.06 bn DKK |
| Net income | 2.39 bn DKK | 1.55 bn DKK |
| Diluted EPS – continuing operations | 13.31 DKK | 11.20 DKK |
Full history since 2002, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Demant A/S
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
More stocks
- Jiangxi Ganfeng Lithium Co Ltd (002460.SZ)
- Sinotruk Hong Kong Ltd (3808.HK)
- Hormel Foods (HRL)
- Generac (GNRC)
- Saputo Inc (SAP.TO)
- Kawasaki Heavy Industries Ltd (7012.T)
- Marks & Spencer Group Plc (MAKSY)
- Skanska AB (SKA B.ST)
- Power Construction Corp of China Ltd (601669.SS)
- Universal Health Services (UHS)
- HKT Trust and HKT Ltd (6823.HK)
- Klepierre SA (LI.PA)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.